BioTime completes direct public offering

BioTime Inc. (NYSE-M:BTX), Alameda, Calif. Business: Gene/Cell therapy, Pulmonary, Diagnostic Date completed: 6/6/13 Type: Direct public offering Raised: $9.1 million Units: 2.2 million Price: $4.16 (...